Announcement PDF BPH GLOBAL LIMITED ACN 009 104 330 12 April 2024 Company Announcements Platform Australian Securities Exchange Report on Initial Trading Results will be included in Company’s Appendix 4C Report The Board of BPH Global Ltd (ASX: BP8) (Company) advises that the Company’s report on the iniKal sales of bird’s nest products will be included in Company’s Form Appendix 4C to be lodged with ASX by no later than 30 April 2024. In its announcement made to the ASX on 20 March 2024 detailing its current 120-day plan (ending 30 June 2024), the Company stated that it anKcipated being able to report on the iniKal sales numbers achieved by its wholly-owned, Chinese-based subsidiary Foshan Gedishi Biotechnology Co Ltd (Foshan) in the period from January to mid-February prior to Chinese New Year holiday period (Ini-al Sales Period) by the end of March. Due to a number of factors, including integraKon issues arising from the acquisiKon of Foshan, the accounKng treatment of revenue received and booked respecKvely and liaison with the Company’s auditors regarding those accounKng issues, the finalised trading results are not yet complete. - END Authorised for lodgement by the Board of the Company For further information, please visit our website at www.bp8global.com or contact: Mr Paul Stephenson BPH Global Limited Chairman E: pauls@bp8global.com Address: Block Arcade, Office 324, Level 3, 96 Elizabeth St, Melbourne, VIC, 3000